Brief: ALX Oncology Holdings Q1 GAAP Loss Per Share $0.60
May 9 (Reuters) - ALX Oncology Holdings Inc ALXO.O :
* ALX ONCOLOGY REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
AND
PROVIDES CLINICAL DEVELOPMENT AND OPERATIONAL HIGHLIGHTS
* Q1 GAAP LOSS PER SHARE $0.60
* Q1 EARNINGS PER SHARE VIEW $-0.71 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX9VssCx
Further company coverage: ALXO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ALX Oncology Holdings
See all newsALX Oncology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
ALX Oncology Holdings Inc expected to post a loss of 15 cents a share - Earnings Preview
ALX Oncology Q2 net loss narrows on lower R&D costs
Brief: ALX Oncology Q2 Basic EPS USD -0.13
Brief: Alx Oncology Holdings - Enters Loan And Security Agreement With HSBC Ventures On June 25, 2026 - SEC Filing